Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

107.25
-5.1400-4.57%
Post-market: 106.50-0.7500-0.70%19:59 EDT
Volume:12.92M
Turnover:1.41B
Market Cap:133.56B
PE:282.24
High:112.87
Open:110.51
Low:107.12
Close:112.39
Loading ...

Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Yesterday

4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues

Zacks
·
04 Apr

11 Stocks to Buy After the Biotech Bloodbath -- Barrons.com

Dow Jones
·
04 Apr

Pharma Stocks Survive Market Rout on Tariff Exemption, but Uncertainty Continues

Reuters
·
03 Apr

Gilead : RBC Cuts Target Price to $89 From $90

THOMSON REUTERS
·
03 Apr

RBC Trims Price Target on Gilead Sciences to $89 From $90, Keeps Sector Perform Rating

MT Newswires Live
·
03 Apr

Bernstein Sticks to Its Buy Rating for Gilead Sciences (GILD)

TIPRANKS
·
03 Apr

Gilead Sciences (GILD) Ascends But Remains Behind Market: Some Facts to Note

Zacks
·
03 Apr

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks
·
01 Apr

Discovering a Breakthrough: Gilead’s Long-Standing Commitment to Helping Change the Course of HIV

ACCESS Newswire
·
01 Apr

Pharma Stocks Sink After Ouster of Top FDA Vaccine Regulator

Reuters
·
31 Mar

1 Healthcare Stock to Target This Week and 2 to Turn Down

StockStory
·
31 Mar

Fiery Resignation of Top FDA Official Sparks Biotech Selloff -- Barrons.com

Dow Jones
·
31 Mar

Gilead Sciences (NasdaqGS:GILD) Faces Shareholder Proposals As Stock Rises 5%

Simply Wall St.
·
29 Mar

BRIEF-Gilead Says CEO Daniel O’Day's 2024 Total Compensation Was $23.7 Million - SEC Filing

Reuters
·
28 Mar

Gilead Says CEO Daniel O’day's 2024 Total Compensation Was $23.7 Mln - SEC Filing

THOMSON REUTERS
·
28 Mar

Gilead - Board Recommends to Vote Against Stockholder Proposal Requesting Report on Risks of Co's Dei Practices for Contractors

THOMSON REUTERS
·
28 Mar

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2025-03-27

Reuters
·
28 Mar

Gilead Sciences Is Maintained at Overweight by JP Morgan

Dow Jones
·
27 Mar

Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead. -- Barrons.com

Dow Jones
·
27 Mar